This session will highlight the cardiovascular, renal, and metabolic approach recommended by NICE and will be illustrated with real-world case studies to help you navigate the multiple treatment options available.

Key learning objectives

• Increased understanding of the latest NICE recommendations for managing type 2 diabetes.
• Learn how to manage type 2 diabetes effectively early after diagnosis, emphasising the importance of glycaemic control and cardiovascular risk reduction.
• Understand strategies for managing more complex cases of type 2 diabetes later in the course of the disease.
• Explore safe use of SGLT2 inhibitors and other medications in the treatment of type 2 diabetes.

AstraZeneca has provided sponsorship towards this independent programme. AstraZeneca has had no editorial input into or control over the agenda, content development or choice of speakers, nor opportunity to influence except for the AstraZeneca sponsored symposia.